Dotinurad Study Sets Week 24 Comparison With Allopurinol in Gout
A trial record describes a study comparing dotinurad with allopurinol in adults with gout-associated hyperuricemia, focused on serum uric acid at Week 24.
Posted by Daniel Zaharia | Sep 28, 2026 | Health |
A trial record describes a study comparing dotinurad with allopurinol in adults with gout-associated hyperuricemia, focused on serum uric acid at Week 24.
Posted by Daniel Zaharia | Sep 25, 2026 | Health |
A ClinicalTrials.gov record describes a planned 20-person study comparing four lower-limb radiofrequency therapy protocols in people with Parkinson’s disease, with immediate and 48-hour assessments of stiffness, mobility, pain and safety.
Read MorePosted by Daniel Zaharia | Sep 24, 2026 | Health |
A ClinicalTrials.gov entry describes a study of fixed-dose bictegravir, emtricitabine and tenofovir alafenamide in adolescents and children with HIV-1, focused on how the combination is handled by the body, dose confirmation, safety and tolerability.
Read MorePosted by Daniel Zaharia | Sep 23, 2026 | Health |
A ClinicalTrials.gov entry describes a Phase I study of RNA–lipid particle vaccines for adults with recurrent glioblastoma, focused on manufacturing feasibility, safety and maximum tolerated dose.
Read MorePosted by Daniel Zaharia | Sep 22, 2026 | Health |
A ClinicalTrials.gov listing describes a Phase 3 trial of CBL-514 injection for abdominal subcutaneous fat, using a randomized, double-blinded, placebo-controlled design.
Read More